Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cue Biopharma Inc
(NQ:
CUE
)
1.210
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cue Biopharma Inc
< Previous
1
2
3
4
5
Next >
12 Health Care Stocks Moving In Friday's Pre-Market Session
October 11, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
October 10, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
October 09, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
October 07, 2024
Via
Benzinga
Forecasting The Future: 4 Analyst Projections For Cue Biopharma
April 09, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
October 07, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
October 04, 2024
Via
Benzinga
Cue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting
October 04, 2024
From
Cue Biopharma, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's Intraday Session
October 03, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
September 30, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
September 27, 2024
Via
Benzinga
Cue Biopharma Announces Pricing of $12.0 Million Public Offering
September 26, 2024
From
Cue Biopharma, Inc.
Via
GlobeNewswire
Cue Biopharma Announces Proposed Public Offering
September 26, 2024
From
Cue Biopharma, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
September 26, 2024
Via
Benzinga
Cue Biopharma Announces Proposed Public Offering
September 26, 2024
From
Cue Biopharma, Inc.
Via
GlobeNewswire
Cue Biopharma Appoints Industry Veteran Lucinda Warren as Chief Business Officer
September 09, 2024
From
Cue Biopharma, Inc.
Via
GlobeNewswire
Cue Biopharma to Present at The Promise of Interleukin-2 Therapy Conference
September 03, 2024
From
Cue Biopharma, Inc.
Via
GlobeNewswire
Cue Biopharma Reports Second Quarter 2024 Financial Results and Recent Business Highlights
August 19, 2024
From
Cue Biopharma, Inc.
Via
GlobeNewswire
CUE Stock Earnings: Cue Biopharma Beats EPS, Beats Revenue for Q2 2024
August 15, 2024
CUE stock results show that Cue Biopharma beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Cue Biopharma to Host Business Update Call and Webcast
August 13, 2024
From
Cue Biopharma, Inc.
Via
GlobeNewswire
Cue Biopharma Announces Strategic Prioritization of Autoimmune Programs Enabling Optimization of Workforce and Reduction of Capital Requirements
July 25, 2024
From
Cue Biopharma, Inc.
Via
GlobeNewswire
Cue Biopharma Presents Updated Data from Phase 1 Trial of CUE-101 in Recurrent/Metastatic HPV+ Head and Neck Cancer at the 2024 ASCO Annual Meeting
June 04, 2024
From
Cue Biopharma, Inc.
Via
GlobeNewswire
Cue Biopharma to Present at Two Upcoming Investor Healthcare Conferences in June 2024
June 03, 2024
From
Cue Biopharma, Inc.
Via
GlobeNewswire
Medical Moonshots: 3 Biotech Stocks Set to Skyrocket
May 30, 2024
Though risky, investors who buy biotech stocks watch their portfolios skyrocket when their drugs work as intended.
Via
InvestorPlace
CUE Stock Earnings: Cue Biopharma Beats EPS, Beats Revenue for Q1 2024
May 09, 2024
CUE stock results show that Cue Biopharma beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Cue Biopharma Reports First Quarter 2024 Financial Results and Recent Business Highlights
May 09, 2024
From
Cue Biopharma, Inc.
Via
GlobeNewswire
Cue Biopharma to Present at the 20th Annual PEGS Boston Summit
May 08, 2024
From
Cue Biopharma, Inc.
Via
GlobeNewswire
Cue Biopharma to Participate in Fireside Chat at The Citizens JMP Life Sciences Conference
May 07, 2024
From
Cue Biopharma, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
May 02, 2024
Via
Benzinga
Cue Biopharma to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
April 24, 2024
From
Cue Biopharma, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.